Drug delivery, disposition and dynamics (D4)

Drug Delivery, Disposition and Dynamics

The Drug delivery, disposition and dynamics (D4) research teams within the Monash Institute of Pharmaceutical Sciences (MIPS) are designing and developing the next generation of drug delivery systems and anti-infective agents to enhance medicine effectiveness and patient treatment.

Ben Boyd

Research areas

Find a researcher



Contact us

+61 3 9903 9614
nicki.penny@monash.edu

Find a D4 PhD project

We're looking for the brightest biomedical science, pharmaceutical science and pharmacy talent to join our ambitious, curious and groundbreaking research teams. We want to change the world and you can help us.

See the latest news

Search news

Browse by category

Browse: ▾

Select all - Clear all

Monash receives $5m grant to make COVID-19 mRNA vaccine for clinical trials

Monash University has received $5 million from the Victorian Government to manufacture the first Australian batch of a COVID-19 mRNA vaccine for clinical trials, using a vaccine candidate developed by researchers from the Monash Institute of
Medicine & health

Next-gen antibiotic developed by Monash University enters clinical trials

In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria - also known as ‘superbugs’ - a new antibiotic (QPX9003) discovered by Monash University researchers has entered
Research

Monash University drug researchers discover potent class of molecules that kills malaria parasite

A world-leading team of antimalarial researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) have discovered a new class of molecules capable of killing Plasmodium falciparum, the parasite that causes malaria in humans through the
Research

MIPS researcher awarded for knowledge commercialisation

Professor Jonathan Baell and colleagues from WEHI were recognised for their work in developing a new cancer treatment.
Research
Elderly woman looking at mobile phone next to a masked woman

New research highlights potential overtreatment and undertreatment of diabetes in residential aged care

A new international study led by Monash University has found that residents with type 2 diabetes in residential aged care are potentially being overtreated – or missing out on treatment altogether.
Research

Scientists develop novel tools to gain new insights into an important therapeutic target

A team of researchers, led by the Monash Institute of Pharmaceutical Sciences (MIPS) have, for the first time, developed a tool that will enable the wider scientific community to gain a deeper understanding of how the human adenosine A1 receptor
Research
Chemotherapy drugs in vials and bottles against a black background

Leading drug researchers join forces to tackle chemotherapy-induced heart damage

A team of researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and the Murdoch Children’s Research Institute (MCRI) have collaborated to develop novel small molecules with the aim to protect heart muscle cells from
Research

Monash University Dean recognised among nation’s most distinguished scientists

Professor Arthur Christopoulos, Dean of Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, has been elected a Fellow of the Australian Academy of Science (FAA) for his ground-breaking research and outstanding contributions to

World #2 launches new Master of Pharmaceutical Science

Monash University has launched a new postgraduate degree to address a major skills shortage in the Australian pharmaceutical sector and its allied industries.